Search For "hydroxychloroquine"
Fighting Covid: Govt mulling to discontinue Azithromycin on critical patie
Updated : 5 years, 9 months ago IST
New Delhi [India], June 12 (ANI): The Ministry of Health and Family Welfare is likely to withdraw the use of Azithromycin, which was being administered to severely ill COVID-19 patients in the intensive care units (ICUs), from the combination of Azithromycin and Hydroxychloroquine (HCQ).<
Read More
Production of Hydroxychloroquine more than requirement: Mansukh Mandaviya
Updated : 5 years, 9 months ago IST
New Delhi [India], June 11 (ANI): Union Minister of State for Chemicals and Fertilizers, Mansukh Mandaviya said that the production of Hydroxychloroquine is more than the requirement in India, hence the government has lifted export restrictions on it.
Read More
Authors retract Lancet study on HCQ drug over unavailability of full data
Updated : 5 years, 9 months ago IST
Washington D.C. [USA], June 5 (ANI): Three authors involved in a Lancet article that drew scrutiny over the trial of the antimalarial drug-- hydroxychloroquine-- for curing patients infected with COVID-19 said they retracted items related to it over unavailability of full data set behind the
Read More
WHO decision to stop HCQ trial was a knee jerk reaction, says CSIR DG
Updated : 5 years, 9 months ago IST
New Delhi [India], June 4 (ANI): CSIR Director-General Shekhar Mande said on Thursday that the World Health Organisation's (WHO) decision to halt hydroxychloroquine (HCQ) drug trial was taken in haste and the global body should have actually analysed the data before making the decision.
Read More
Four or more dosage of HCQ showed significant decline of covid19 among hea
Updated : 5 years, 9 months ago IST
New Delhi [India], June 1 (ANI): Citing noteworthy benefits of Hydroxychloroquine (HCQ) prophylaxis against coronavirus, the Indian Council of Medical Research (ICMR) has revealed that the consumption of four or more doses of the antimalarial drug- (HCQ), has shown a significant decline of C
Read More
Halting hydroxychloroquine trials based on faulty Lancet study is 'knee je
Updated : 5 years, 10 months ago IST
New Delhi [India], May 30 (ANI): Council of Scientific and Industrial Research (CSIR) Director-General Shekhar Mande, Institute of Genomics and Integrative Biology (IGIB) Delhi Director Anurag Agarwal and Chennai Mathematical Institute (CMI) Chennai Director Rajeev Karandikar have written to
Read More
ICMR writes to WHO disagreeing with HCQ assessment, officials say internat
Updated : 5 years, 10 months ago IST
New Delhi [India], May 29 (ANI): After the Union Health Ministry expressed reservations about the World Health Organisation's (WHO) advisory to suspend hydroxychloroquine (HCQ) usage in treating COVID-19 patients, now, India's nodal government agency ICMR (Indian Council of Medical Research)
Read More
No talks between Prime Minister Modi and Trump on Ladakh: Sources
Updated : 5 years, 10 months ago IST
New Delhi [India], May 29 (ANI): The last conversation between Prime Minister Narendra Modi and US President Donald Trump took place on April 4, 2020, on the subject of hydroxychloroquine, informed sources over the matter told ANI on Friday.
Read More
France officially bans hydroxychloroquine as treatment against COVID-19
Updated : 5 years, 10 months ago IST
Paris [France], May 28 (Sputnik/ANI): France on Wednesday (local time) officially banned hydroxychloroquine as a treatment for COVID-19 after a series of medical studies revealed that the malaria drug could be harmful.
Read More
Trust ICMR's judgement on hydroxychloroquine in covid treatment, says CSIR
Updated : 5 years, 10 months ago IST
New Delhi [India], May 27 (ANI): Director General of the Council of Scientific and Industrial Research (CSIR), Shekher Mande, on Wednesday said the Indian Council of Medical Research's (ICMR) conclusion of hydroxychloroquine (HCQ) having no major side-effects in the treatment of Covid-inf
Read More
Lancet study is not randomised clinical trial, only analysis of hospital r
Updated : 5 years, 10 months ago IST
New Delhi [India], May 27 (ANI): Dismissing the reports of health risks from Hydroxychloroquine (HCQ) as per simmering reports cited by the World Health Organisation (WHO), Shekher Mande, Director General of the Council of Scientific and Industrial Research (CSIR), India, said on Wednesday t
Read More
Decided not to deny health workers HCQ based on risk-benefit analysis: ICM
Updated : 5 years, 10 months ago IST
New Delhi [India], May 26 (ANI): Noting that a lot of drugs are being repurposed for treatment of COVID-19, ICMR Director-General Dr Balram Bhargava on Tuesday said that prophylactic use of Hydroxychloroquine (HCQ) for health care workers had been recommended on the basis of risk-benefit a
Read More